According to Fortune Business Insights, the global plasma fractionation market was valued at USD 37.31 billion in 2024 and is projected to grow from USD 40.27 billion in 2025 to USD 72.45 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.8% during the forecast period. In 2024, North America dominated the market with a 56.18% share.
